Veronika Temml

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

Journal of chemical information and modeling

Biomedicines

Cancers

Journal of enzyme inhibition and medicinal chemistry

Universität Innsbruck

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Innsbruck Jan 1o 2015

Austria

post doctoral researcher :: Pharmacognosy

Publications

Veronika Temml, Jakub Kollár, Theresa Schönleitner, Anna Höll, Daniela Schuster, Zsófia Kutil
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors. Journal of chemical information and modeling 63 (4) (2023)
Miroslav Sisa, Lukáš Konečný, Veronika Temml, Alejandro Carazo, Přemysl Mladěnka, Přemysl Landa
SC-560 and mofezolac isosteres as new potent COX-1 selective inhibitors with antiplatelet effect. Archiv der Pharmazie (2023)
Veronika Temml, Jakub Kollár, Theresa Schönleitner, Anna Höll, Daniela Schuster, Zsófia Kutil
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors. Journal of chemical information and modeling 63 (4) (2023)
Lukas Zell, Alina Bretl, Veronika Temml, Daniela Schuster
Dopamine Receptor Ligand Selectivity-An In Silico/In Vitro Insight. Biomedicines 11 (5) (2023)
Veronika Temml, Jakub Kollár, Theresa Schönleitner, Anna Höll, Daniela Schuster, Zsófia Kutil
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors. Journal of chemical information and modeling 63 (4) (2023)
Veronika Temml, Jakub Kollár, Theresa Schönleitner, Anna Höll, Daniela Schuster, Zsófia Kutil
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors. Journal of chemical information and modeling 63 (4) (2023)
Veronika Temml, Jakub Kollár, Theresa Schönleitner, Anna Höll, Daniela Schuster, Zsófia Kutil
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors. Journal of chemical information and modeling (2023)
Mark James Horgan, Lukas Zell, Bianka Siewert, Hermann Stuppner, Daniela Schuster, Veronika Temml
Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico / In Vitro Approach. Journal of chemical information and modeling (2023)
Lisa Vieider, Eva Zoeller, Erik Romp, Martin Schoenthaler, Victor Hernández-Olmos, Veronika Temml, Thomas Hasenoehrl, Daniela Schuster, Oliver Werz, Ulrike Garscha, Barbara Matuszczak
Synthesis and structure-activity relationships for some novel diflapolin derivatives with benzimidazole subunit. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Sandra Piras, Gabriele Murineddu, Giovanni Loriga, Antonio Carta, Enrica Battistello, Stefania Merighi, Stefania Gessi, Paola Corona, Battistina Asproni, Roberta Ibba, Veronika Temml, Daniela Schuster, Gérard Aimè Pinna
Biological Effects on μ-Receptors Affinity and Selectivity of Arylpropenyl Chain Structural Modification on Diazatricyclodecane Derivatives. Molecules (Basel, Switzerland) 26 (18) (2021)
Mona Kafka, Fabian Mayr, Veronika Temml, Gabriele Möller, Jerzy Adamski, Julia Höfer, Stefan Schwaiger, Isabel Heidegger, Barbara Matuszczak, Daniela Schuster, Helmut Klocker, Jasmin Bektic, Hermann Stuppner, Iris E Eder
Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer. Cancers 12 (8) (2020)

Veronika Temml.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Veronika Temml